Ghent University Academic Bibliography

Your filters: cql: author="Han, Joseph K" or (type any "bookEditor issueEditor" and editor="Han, Joseph K")

Add to list
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Joaquim Mullol, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter W Hellings, Joseph K Han, Roger Jankowski, Jan Vodicka, Philippe Gevaert (UGent) , Nadia Daizadeh, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(4). p.1086-1095.e5
Add to list
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE) : a randomised, double-blind, placebo-controlled, phase 3 trial

Joseph K Han, Claus Bachert (UGent) , Wytske Fokkens, Martin Desrosiers, Martin Wagenmann, Stella E Lee, Steven G Smith, Neil Martin, Bhabita Mayer, Steven W Yancey, et al.

(2021) LANCET RESPIRATORY MEDICINE. 9(10). p.1141-1153
Add to list
Efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps : results from the randomized phase 3 sinus-24 study

Joseph K Han, Claus Bachert (UGent) , Martin Desrosiers, Tanya M Laidlaw, Claire Hopkins, Wytske J Fokkens, Pierluigi Paggiaro, Seong Ho Cho, Heidi Olze, Leon S Greos, et al.

(2019) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 143(2, suppl.). p.AB422-AB422
Add to list
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) : results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert (UGent) , Joseph K Han, Martin Desrosiers, Peter W Hellings, Nikhil Amin, Stella E Lee, Joaquim Mullol, Leon S Greos, John V Bosso, Tanya M Laidlaw, et al.

(2019) LANCET. 394(10209). p.1638-1650

Academic Bibliography

Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE) : a randomised, double-blind, placebo-controlled, phase 3 trial

Efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps : results from the randomized phase 3 sinus-24 study

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) : results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Contents

Support

Contact